Marketable Securities, Current in USD of CAPRICOR THERAPEUTICS, INC. from Q4 2012 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of investment in marketable security, classified as current.
Summary
CAPRICOR THERAPEUTICS, INC. quarterly Marketable Securities, Current history and change rate from Q4 2012 to Q3 2025.
  • CAPRICOR THERAPEUTICS, INC. Marketable Securities, Current for the quarter ending 30 Sep 2025 was $79.1M, a 375% increase year-over-year.
Marketable Securities, Current, Quarterly (USD)
Marketable Securities, Current, YoY Quarterly Change (%)

CAPRICOR THERAPEUTICS, INC. Quarterly Marketable Securities, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $79.1M +$62.4M +375% 30 Sep 2025 10-Q 10 Nov 2025
Q2 2025 $99.6M +$80.8M +430% 30 Jun 2025 10-Q 11 Aug 2025
Q1 2025 $116M +$82.3M +244% 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $140M +$115M +466% 31 Dec 2024 10-Q 10 Nov 2025
Q3 2024 $16.7M -$2.89M -14.8% 30 Sep 2024 10-Q 14 Nov 2024
Q2 2024 $18.8M -$9.18M -32.8% 30 Jun 2024 10-Q 08 Aug 2024
Q1 2024 $33.7M -$864K -2.5% 31 Mar 2024 10-Q 14 May 2024
Q4 2023 $24.8M -$7.03M -22.1% 31 Dec 2023 10-K 26 Mar 2025
Q3 2023 $19.5M -$18.7M -48.9% 30 Sep 2023 10-Q 14 Nov 2023
Q2 2023 $28M -$7.07M -20.2% 30 Jun 2023 10-Q 08 Aug 2023
Q1 2023 $34.6M 31 Mar 2023 10-Q 12 May 2023
Q4 2022 $31.8M +$31.8M 31 Dec 2022 10-K 11 Mar 2024
Q3 2022 $38.2M 30 Sep 2022 10-Q 10 Nov 2022
Q2 2022 $35M 30 Jun 2022 10-Q 12 Aug 2022
Q4 2021 $0 31 Dec 2021 10-K 17 Mar 2023
Q3 2020 $0 $0 30 Sep 2020 10-Q 13 Nov 2020
Q2 2020 $0 $0 30 Jun 2020 10-Q 10 Aug 2020
Q1 2020 $0 $0 31 Mar 2020 10-Q 15 May 2020
Q4 2019 $5.99M +$2.99M +99.7% 31 Dec 2019 10-K 15 Mar 2021
Q3 2019 $0 -$5.99M -100% 30 Sep 2019 10-Q 08 Nov 2019
Q2 2019 $0 -$6M -100% 30 Jun 2019 10-Q 08 Aug 2019
Q1 2019 $0 -$6M -100% 31 Mar 2019 10-Q 14 May 2019
Q4 2018 $3M -$4.99M -62.5% 31 Dec 2018 10-K 27 Mar 2020
Q3 2018 $5.99M +$996K +19.9% 30 Sep 2018 10-Q 14 Nov 2018
Q2 2018 $6M +$2M +49.9% 30 Jun 2018 10-Q 13 Aug 2018
Q1 2018 $6M -$3M -33.3% 31 Mar 2018 10-Q 14 May 2018
Q4 2017 $7.98M -$5.01M -38.5% 31 Dec 2017 10-K 29 Mar 2019
Q3 2017 $5M +$2.5M +99.9% 30 Sep 2017 10-Q 14 Nov 2017
Q2 2017 $4M +$1.5M +59.9% 30 Jun 2017 10-Q 14 Aug 2017
Q1 2017 $8.99M +$6.49M +260% 31 Mar 2017 10-Q 15 May 2017
Q4 2016 $13M +$4.99M +62.4% 31 Dec 2016 10-K 22 Mar 2018
Q3 2016 $2.5M -$10.5M -80.8% 30 Sep 2016 10-Q 14 Nov 2016
Q2 2016 $2.5M -$13M -83.9% 30 Jun 2016 10-Q 15 Aug 2016
Q1 2016 $2.5M -$13M -83.9% 31 Mar 2016 10-Q 13 May 2016
Q4 2015 $8M +$8M 31 Dec 2015 10-K 16 Mar 2017
Q3 2015 $13M +$12.7M +3896% 30 Sep 2015 10-Q 13 Nov 2015
Q2 2015 $15.5M +$15.2M +4656% 30 Jun 2015 10-Q 14 Aug 2015
Q1 2015 $15.5M +$15.2M +4646% 31 Mar 2015 10-Q 13 May 2015
Q4 2014 $0 -$326K -100% 31 Dec 2014 10-K 30 Mar 2016
Q3 2014 $325K 30 Sep 2014 10-Q 14 Nov 2014
Q2 2014 $326K 30 Jun 2014 10-Q 14 Aug 2014
Q1 2014 $326K 31 Mar 2014 10-Q 15 May 2014
Q4 2013 $326K -$3.87M -92.2% 31 Dec 2013 10-K 16 Mar 2015
Q4 2012 $4.19M 31 Dec 2012 10-K 31 Mar 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.